Liver Biopsy Market Outlook 2018 | Globally Grow at a CAGR of 4.2% by Revenue with Becton, Dickinson and Company, Medtronic, Argon Medical Devices, Inc. till 2023

The Global Liver Biopsy Market is estimated to show significant growth with a CAGR of ~4.2% during the forecast period 2018-2023. Liver Biopsy is a process of obtaining a small piece of liver by a small surgical needle for further diagnostic tests. This test is done to check for Liver cirrhosis, cancer, non-alcoholic fatty liver disease, chronic hepatitis B or C, and autoimmune hepatitis. The most common type of liver biopsy practised is percutaneous liver biopsy which involves inserting a needle through your abdomen into the liver and removing a small piece of tissue. Two other types of liver biopsy are transjugular in which a vein in the neck is used and (laparoscopic) method uses a small abdominal incision to remove liver tissue with a needle.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/5534 .

With the increasing addiction to alcohol and drugs, prevalence of liver diseases have increased. With the rising prevalence of liver diseases, growth in medical technology, availability of diagnostic methods, favourable reimbursement and insurance policies are accelerating the market growth. Whereas, high expense of this test, availability of other non-invasive tests like fluoroscopy, contrast ultrasound and other blood tests for diagnosis of liver disease and side effects associated with liver biopsy test such as Intrahepatic hematoma, Bacterimia, Fever and Dizziness are hindering the market growth.

Liver Biopsy Market - Key Players

Some of key the players in the market are Becton, Dickinson and Company, MDxHealth, Veran medical, Medtronic, Argon Medical Devices, Inc., Mauna Kea Technologies, Boston Scientific Corporation, Intact Medical Corp., C. R. Bard, Inc., Leica Biosystems, Cook Medical, RI.MOS., Hologic, Inc., Sterylab, INRAD Inc., Fujifilm Medical Systems, and others.

Liver Biopsy Market - Competitive Analysis

Medtronic headquartered in Ireland has been solving healthcare challenges with its innovative solutions for more than half a century. Medtronic acquired Coviden In 2015 and reshaped its business structure in Medical devices. In year 2015, Medtronic launched SharkCore™ FNB needle which is a pioneering development in the Fine Needle Biopsy market for diagnosis of cancerous tumours adjacent to the GI tract, and benign liver tissue. This product showed five times increased sales than the other two products Beacon™ FNF Needle and Beacon™ FNA Exchange System.

Boston Scientific Corporation with its eminent team of R&D professionals has been a top pharmaceutical with a huge global presence since 1979. This company launched Acquire Endoscopic Ultrasound Fine Needle Biopsy (FNB) Device, initially in May 2016 and was in full launch in January 2017. The Acquire Fine Needle Biopsy Device is designed to sample targeted tissue sample from liver, pancreas and stomach through the accessory channel of a curvilinear echoendoscope. EUS guided liver biopsy is a newer approach for performing liver biopsy as it is efficient and provides adequate diagnostic tissue for histological evaluation. This reason has made the product gain popularity among gastroenterologists and hepatologists. Apart from this product Boston Scientific Corporation has two more products namely Expect Slimline (SL) endoscopic ultrasound aspiration needle and Expect™19ga Flex Needle used in liver biopsy

Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/5534 .

Liver Biopsy Market - Segmentation

The Global Liver Biopsy Market is segmented on the basis of type, indication, and end user.

On the basis of the diagnosis, it is segmented into percutaneous, transjugular, and laparoscopic biopsy.

On the basis of indication, it is segmented into nonalcoholic fatty liver disease, chronic hepatitis B or C, autoimmune hepatitis, alcoholic liver disease, and others.

Based on the end user, it is segmented into hospitals & clinics, tertiary care centers, urology centers, and others.

Liver Biopsy Market - Intended Audience

Research and Development (R&D) Companies
Ambulatory Care Centers
Academic Institutes and Universities
Biotechnology Companies
Medical Device Manufacturers
Medical Device Suppliers
Market Research and Consulting Service Providers
Potential Investors

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued….

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/5534 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.